))
Dyslipidemia Therapy
Manage episode 371498466 series 3456065
Content provided by Fitzgerald Health Education Associates. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fitzgerald Health Education Associates or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A 65-year-old woman has hypertension, dyslipidemia, type 2 diabetes, a 50 pack-year history of cigarette smoking, currently smoking ½ PPD, and stage 3B chronic kidney disease (CKD) (GFR = 37 mL/min/1.73 m2). She is not currently taking any dyslipidemia therapy and her LDL= 140 mg/dL. Which of the following represents the most appropriate pharmacologic intervention for treatment of dyslipidemia?
A. Owing to her age and comorbidity, no further intervention is required.
B. Moderate-intensity statin therapy is the preferred treatment option.
C. Niacin should be prescribed.
D. The use of ezetimibe (Zetia®) will likely be sufficient to achieve dyslipidemia control.
---
YouTube: https://www.youtube.com/watch?v=up_iIweB9Ic&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=27
Visit fhea.com to learn more!
76 episodes
Share
